As of 2025-09-18, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -91.49 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -91,590.00%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 91,590.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -91.49 - -91.49 | -91.49 | -91,590.00% |
| P/E | (203.47) - (285.08) | (253.43) | -253526.9% |
| DDM - Stable | (111.92) - (345.71) | (228.82) | -228915.3% |
| DDM - Multi | (90.36) - (231.40) | (131.64) | -131735.4% |
| Market Cap (mil) | 0.16 |
| Beta | -2.13 |
| Outstanding shares (mil) | 1.64 |
| Enterprise Value (mil) | -4.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.10% |
| Cost of Debt | 5.00% |
| WACC | 7.89% |